MICHAEL WEISS: Open Payments
NPI 1154350684 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,272 in 126 payments from 26 companies in 2025. Trend: 2023 $2,088 · 2024 $2,191 · 2025 $2,272
Food & beverage: $2,272
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $472 |
| ViiV Healthcare Company | 15 | $349 |
| AstraZeneca Pharmaceuticals LP | 12 | $207 |
| Gilead Sciences, Inc. | 9 | $195 |
| Novo Nordisk Inc | 9 | $155 |
| Amgen Inc. | 9 | $154 |
| PFIZER INC. | 6 | $127 |
| Exact Sciences Corporation | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Theratechnologies Inc. | 2 | $52 |
Products named: APRETUDE, UBRELVY, VRAYLAR, QULIPTA, AIRSUPRA, NURTEC ODT, OTEZLA, DOVATO.
Industry payments across OH — which companies pay providers there.
